Prospective Registry of Epicardial LV Leads Placed During Cardiac Surgery Procedures
- Conditions
- Chronic Heart Failure
- Interventions
- Procedure: Epicardial left ventricular lead placementProcedure: Transvenous left ventricular lead implant
- Registration Number
- NCT00288288
- Lead Sponsor
- University of Kansas
- Brief Summary
The primary purpose of this study is to compare the time, risk and cost savings of 2 patient groups who receive FDA approved left ventricular pacing leads.
- Detailed Description
The purpose of this study is to: a) examine the usefulness of placing an epicardial LV lead at the time of open chest surgery in patients who are likely to benefit from a CRT system following their surgery; b) compare differences between patients who receive LV leads using the transvenous approach and those patients who receive LV leads using the epicardial approach; and c) assess the cost effectiveness of placing the LV lead via the transvenous versus the epicardial approaches.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Left ventricular ejection fraction < or = 35%
- QRS duration greater than or = to 120ms
- NYHA Functional Class 3 or 4
- Age > or = to 18 years
- No previous pacemaker or ICD implant
- No permanent atrial fibrillation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Epicardial left ventricular lead placement Epicardial left ventricular lead placement during a clinically indicated open chest surgery 2 Transvenous left ventricular lead implant Transvenous left ventricular lead implant during a clinically indicated CRT system implant
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States